# K033884: Randox Amikacin

- Pathway: 510(k) (Traditional)
- Applicant: Randox Laboratories, Ltd.
- Decided: Jun 9, 2004 after 177 days
- Product code: KLQ (Radioimmunoassay, Amikacin)
- Device class: 2
- Regulation: 21 CFR 862.3035
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
No later device cites it as a predicate yet.
0 of 1 device in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. FDA’s file for it is a 510(k) statement, which names no predicate.

## Indications for use
The Randox Laboratories Limited Amikacin Test Kit is an in vitro diagnostic reagent for the quantitative determination of amikacin in serum. The method is a latex-enhanced immunoturbidimetric assay based on the principle of measuring changes in scattered light. Latex particles are coated with amikacin, which in the presence of amikacin antibody solution, rapidly agglutinate. When a sample containing amikacin is introduced the agglutination reaction is partially inhibited, slowing down the agglutination process. The rate of agglutination is inversely dependent on the concentration of amikacin in the sample. By monitoring the change in scattered light as a change in absorbance, a concentration curve can be obtained. The actual change in absorbance is inversely proportional to the concentration of amikacin in the sample. Measurements obtained by this device are used in the diagnosis and treatment of amikacin use or overdose and in monitoring levels of amikacin to ensure appropriate therapy. This Application Sheet has been developed for the ADVIA® 1650 analyser and must be used by suitably qualified laboratory personnel under appropriate laboratory conditions

Source page: https://510kreport.com/device/K033884
Methodology: https://510kreport.com/methodology